BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17105192)

  • 1. The pertussis toxin S1 subunit is a thermally unstable protein susceptible to degradation by the 20S proteasome.
    Pande AH; Moe D; Jamnadas M; Tatulian SA; Teter K
    Biochemistry; 2006 Nov; 45(46):13734-40. PubMed ID: 17105192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evading the proteasome: absence of lysine residues contributes to pertussis toxin activity by evasion of proteasome degradation.
    Worthington ZE; Carbonetti NH
    Infect Immun; 2007 Jun; 75(6):2946-53. PubMed ID: 17420233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thermal Unfolding of the Pertussis Toxin S1 Subunit Facilitates Toxin Translocation to the Cytosol by the Mechanism of Endoplasmic Reticulum-Associated Degradation.
    Banerjee T; Cilenti L; Taylor M; Showman A; Tatulian SA; Teter K
    Infect Immun; 2016 Dec; 84(12):3388-3398. PubMed ID: 27647866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational instability of the cholera toxin A1 polypeptide.
    Pande AH; Scaglione P; Taylor M; Nemec KN; Tuthill S; Moe D; Holmes RK; Tatulian SA; Teter K
    J Mol Biol; 2007 Dec; 374(4):1114-28. PubMed ID: 17976649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structures of pertussis toxin with NAD
    Sakari M; Tran MT; Rossjohn J; Pulliainen AT; Beddoe T; Littler DR
    J Biol Chem; 2022 May; 298(5):101892. PubMed ID: 35378130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular disassembly and activity of pertussis toxin require interaction with ATP.
    Plaut RD; Scanlon KM; Taylor M; Teter K; Carbonetti NH
    Pathog Dis; 2016 Aug; 74(6):. PubMed ID: 27369899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteolytic cleavage of pertussis toxin S1 subunit is not essential for its activity in mammalian cells.
    Carbonetti NH; Mays RM; Artamonova GV; Plaut RD; Worthington ZE
    BMC Microbiol; 2005 Feb; 5():7. PubMed ID: 15691377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular Trafficking and Translocation of Pertussis Toxin.
    Teter K
    Toxins (Basel); 2019 Jul; 11(8):. PubMed ID: 31349590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of subassemblies of pertussis toxin subunits in vivo and their interaction with the ptl transport apparatus.
    Burns DL; Fiddner S; Cheung AM; Verma A
    Infect Immun; 2004 Sep; 72(9):5365-72. PubMed ID: 15322034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A quantitative analysis for the ADP-ribosylation activity of pertussis toxin: an enzymatic-HPLC coupled assay applicable to formulated whole cell and acellular pertussis vaccine products.
    Cyr T; Menzies AJ; Calver J; Whitehouse LW
    Biologicals; 2001 Jun; 29(2):81-95. PubMed ID: 11580213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxin instability and its role in toxin translocation from the endoplasmic reticulum to the cytosol.
    Teter K
    Biomolecules; 2013 Dec; 3(4):997-1029. PubMed ID: 24970201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrograde transport of pertussis toxin in the mammalian cell.
    Plaut RD; Carbonetti NH
    Cell Microbiol; 2008 May; 10(5):1130-9. PubMed ID: 18201245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenylate cyclase toxin-mediated delivery of the S1 subunit of pertussis toxin into mammalian cells.
    Iwaki M; Konda T
    Pathog Dis; 2016 Feb; 74(1):ftv110. PubMed ID: 26607401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photolabelling of mutant forms of the S1 subunit of pertussis toxin with NAD+.
    Cieplak W; Locht C; Mar VL; Burnette WN; Keith JM
    Biochem J; 1990 Jun; 268(3):547-51. PubMed ID: 2363691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ins and outs of pertussis toxin.
    Locht C; Coutte L; Mielcarek N
    FEBS J; 2011 Dec; 278(23):4668-82. PubMed ID: 21740523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural characteristics of the plasmid-encoded toxin from enteroaggregative Escherichia coli.
    Scaglione P; Nemec KN; Burlingame KE; Grabon A; Huerta J; Navarro-Garcia F; Tatulian SA; Teter K
    Biochemistry; 2008 Sep; 47(36):9582-91. PubMed ID: 18702515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibody that neutralizes pertussis toxin activities.
    Pootong A; Budhirakkul P; Tongtawe P; Tapchaisri P; Chongsa-nguan M; Chaicumpa W
    Asian Pac J Allergy Immunol; 2007 Mar; 25(1):37-45. PubMed ID: 17891920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of mutant strains producing pertussis toxin cross reacting materials.
    Sato Y; Sato H; Chazono M; Ginnaga A; Tamura C
    Dev Biol Stand; 1991; 73():93-107. PubMed ID: 1778339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferential processing of the S1 subunit of pertussis toxin that is bound to eukaryotic cells.
    Finck-Barbançon V; Barbieri JT
    Mol Microbiol; 1996 Oct; 22(1):87-95. PubMed ID: 8899711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of the pertussis toxin-ATP complex: a molecular sensor.
    Hazes B; Boodhoo A; Cockle SA; Read RJ
    J Mol Biol; 1996 May; 258(4):661-71. PubMed ID: 8637000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.